| scholarly article | Q13442814 |
| P2093 | author name string | Ali Gholamrezaei | |
| Mohammad Hashemi-Jazi | |||
| Sayed Mojtaba Hosseini | |||
| P2860 | cites work | Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction. | Q53501749 |
| The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. | Q53824140 | ||
| Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction. | Q55070207 | ||
| Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty | Q71948909 | ||
| Angiographic predictors of a rise in serum creatine kinase (distal embolization) after balloon angioplasty of saphenous vein coronary artery bypass grafts | Q72906506 | ||
| Could direct stenting reduce no-reflow in acute coronary syndromes? A randomized pilot study | Q74328281 | ||
| Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction | Q74576114 | ||
| High cholesterol in patients with ECG signs of no-reflow after myocardial infarction | Q75314944 | ||
| Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention | Q77361734 | ||
| Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts | Q78346407 | ||
| Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention | Q81469716 | ||
| Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction | Q82714915 | ||
| Long-term outcomes of saphenous vein graft stenting compared with native coronary artery stenting in patients with previous coronary artery bypass graft surgery | Q82833937 | ||
| Intravascular ultrasound findings that are predictive of no reflow after percutaneous coronary intervention for saphenous vein graft disease | Q83727669 | ||
| Effect of chronic pretreatment of angiotensin-converting receptor blocker on no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention | Q84940553 | ||
| Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction | Q85317125 | ||
| Transient no reflow following primary percutaneous coronary intervention | Q87013566 | ||
| Mild to Moderate Renal Impairment Is Associated With No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction | Q87579767 | ||
| A new equation to estimate glomerular filtration rate | Q24651973 | ||
| Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era | Q28303142 | ||
| Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention | Q34032366 | ||
| The coronary no-reflow phenomenon: a review of mechanisms and therapies | Q34249574 | ||
| No-reflow phenomenon | Q34517875 | ||
| Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers | Q35025274 | ||
| Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis | Q35163367 | ||
| No-reflow: again prevention is better than treatment | Q37788437 | ||
| 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q37953802 | ||
| Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions | Q38098012 | ||
| The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era. | Q40513556 | ||
| Saphenous vein graft intervention: status report 2014. | Q41721657 | ||
| Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. | Q42540980 | ||
| Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction. | Q42772193 | ||
| Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention | Q43991937 | ||
| Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction | Q44304785 | ||
| The relationship between neutrophil/lymphocyte ratio and the TIMI flow grade in patients with STEMI undergoing primary PCI. | Q44512855 | ||
| Coronary flow slows as renal function worsens. | Q46006245 | ||
| Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction | Q46886146 | ||
| C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction | Q47191457 | ||
| Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. | Q51066932 | ||
| An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for "no-reflow" phenomenon? | Q51150981 | ||
| Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. | Q51590021 | ||
| P433 | issue | 5 | |
| P921 | main subject | coronary artery bypass surgery | Q186020 |
| P304 | page(s) | 221-229 | |
| P577 | publication date | 2017-09-01 | |
| P1433 | published in | ARYA atherosclerosis | Q26853958 |
| P1476 | title | Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts | |
| P478 | volume | 13 |
Search more.